Literature DB >> 26632860

Colchicine for cardiovascular medicine.

Massimo Imazio1, Fiorenzo Gaita2.   

Abstract

Colchicine is an ancient drug with anti-inflammatory effects especially on neutrophils. These cells are critically involved in pericardial and atherosclerotic plaques inflammation, thus representing a new potential target for new therapies to treat and especially prevent cardiovascular events such as pericarditis, atrial fibrillation triggered by inflammation and ischemic vascular events. The aim of the present review is to briefly review the essential pharmacology and explore potential efficacy and safety of colchicine for new emerging cardiovascular indications.

Entities:  

Keywords:  acute coronary syndrome; atrial fibrillation; colchicine; pericarditis; restenosis; stable angina

Mesh:

Substances:

Year:  2015        PMID: 26632860     DOI: 10.2217/fca.15.59

Source DB:  PubMed          Journal:  Future Cardiol        ISSN: 1479-6678


  4 in total

1.  Uric Acid Is Associated With Inflammation, Coronary Microvascular Dysfunction, and Adverse Outcomes in Postmenopausal Women.

Authors:  Megha Prasad; Eric L Matteson; Joerg Herrmann; Rajiv Gulati; Charanjit S Rihal; Lilach O Lerman; Amir Lerman
Journal:  Hypertension       Date:  2016-12-19       Impact factor: 10.190

2.  Allocolchicinoids bearing a Michael acceptor fragment for possible irreversible binding of tubulin.

Authors:  Ekaterina S Sazanova; Iuliia A Gracheva; Diane Allegro; Pascale Barbier; Sébastien Combes; Elena V Svirshchevskaya; Alexey Yu Fedorov
Journal:  RSC Med Chem       Date:  2020-06-04

3.  Pathogenic characteristics and treatment in 43 cases of acute colchicine poisoning.

Authors:  Xiaoxia Lu; Yanqing Liu; Chunyan Wang; Jianguang Dong; Lili Bai; Chengcheng Zhang; Renzheng Zhang; Chengwen Sun; Zewu Qiu
Journal:  Toxicol Res (Camb)       Date:  2021-07-29       Impact factor: 2.680

4.  Synthesis and Biological Evaluation of Novel Triple-Modified Colchicine Derivatives as Potent Tubulin-Targeting Anticancer Agents.

Authors:  Urszula Majcher; Greta Klejborowska; Magdalena Kaik; Ewa Maj; Joanna Wietrzyk; Mahshad Moshari; Jordane Preto; Jack A Tuszynski; Adam Huczyński
Journal:  Cells       Date:  2018-11-19       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.